ArticleRheumatology (Oxford, England)2024

The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort.

Alessandro Tomelleri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.